CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Circadian engineering of in vivo CAR T cell therapy for precision oncology.
Circadian engineering of in vivo CAR T cell therapy for precision oncology.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
昼夜节律通过调节内分泌信号、血管通透性、白细胞迁移、代谢以及肿瘤微环境的免疫抑制特征,在 24 小时周期内塑造抗肿瘤免疫。本综述提出,生物学时间可能是 CAR-T 细胞疗法设计中的一个重要变量。该概念对体内 CAR-T 平台尤其相关,因为此类平台可通过可重复诱导、可调节幅度和可逆关闭,将时间控制扩展至输注时机之外。作者讨论的证据显示,CD8 T 细胞的内在时钟、神经内分泌振荡、内皮细胞把关以及肿瘤微环境的节律性重塑,会影响免疫细胞进入、效应能力、耗竭风险和炎症毒性。综述还考察病毒载体、脂质纳米颗粒和可编程控制线路如何支持考虑昼夜节律的 CAR 安装与工作周期调控。总体而言,这些观察支持将“昼夜节律合成 CAR-T”作为一种可检验的转化研究框架,用于精准免疫肿瘤学。
Circadian rhythms shape antitumor immunity by regulating endocrine signaling, vascular permissiveness, leukocyte trafficking, metabolism, and suppressive features of the tumor microenvironment across the 24-h cycle.
Here, we propose that biological time may represent an important design variable for CAR T-cell therapy. This concept may be particularly relevant to in vivo CAR T platforms, which could extend temporal control beyond infusion timing through repeatable induction, tunable amplitude, and reversible shutdown.
We discuss evidence that CD8 T-cell clocks, neuroendocrine oscillations, endothelial gatekeeping, and rhythmic tumor-microenvironment remodeling influence immune access, effector competence, exhaustion risk, and inflammatory toxicity.
We further examine how viral vectors, lipid nanoparticles, and programmable control circuits might enable circadian-aware CAR installation and duty-cycling.
Together, these observations support chrono-synthetic CAR T as a testable translational framework for precision immuno-oncology.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。